Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/20667Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ivanova, Kateryna | - |
| dc.date.accessioned | 2018-10-25T13:31:02Z | - |
| dc.date.available | 2018-10-25T13:31:02Z | - |
| dc.date.issued | 2018-09-26 | - |
| dc.identifier.citation | Ivanova K. V. Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity / K. V. Ivanova // Український кардіологічний журнал. – 2018. – Додаток 1 : ХІХ Національний конгрес кардіологів України: тези доповідей, Київ, 26–28 вересня 2018. – С. 56. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/20667 | - |
| dc.description.abstract | Recent studies have revealed that fibroblast growth factor 21 (FGF21) plays important role in energy metabolism regulation. FGF21 contributes to many age-related metabolic disorders, e.g. atherosclerosis, obesity, type 2 diabetes, and some cardiovascular diseases | ru_RU |
| dc.language.iso | en | ru_RU |
| dc.subject | fibroblast growth factor 21 | ru_RU |
| dc.subject | dyslipidemia | ru_RU |
| dc.subject | coronary artery disease | ru_RU |
| dc.title | Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity | ru_RU |
| dc.type | Thesis | ru_RU |
| Appears in Collections: | Наукові праці. Кафедра загальної практики – сімейної медицини та внутрішніх хвороб | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| конгресс-pages-15.pdf | 90,06 kB | Adobe PDF |  View/Open | |
| укж.pdf | 144,74 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.